| Acorda Therapeutics, Inc – Steven Schwid, MD Memorial Research Scholar | |
|---|---|
| Jyotsna Mullur Dr. Peter Riskind and Dr. Carolina Ionete |
Analysis of the 25 Foot Times Walk Test as a Predictive Factor in Multiple Sclerosis |
| FCMSC – June Halper Research Scholar | |
| Hunter Vincent Dr. Mary Ann Picone |
Utilizing Technology to Improve Patient Adherence and Professional Patient Monitoring for at-home exercise program in patients with Multiple Sclerosis |
| FCMSC Robert P. Lisak, MD Research Scholar | |
| Kimberly Pater Dr. John Lindsey |
Autoimmunity to Mitochondrial Proteins in Multiple Sclerosis |
| Genentech Research Scholars | |
| Matthew M. Engelhard Dr. Myla Goldman |
Toward a probabilistic, adaptive assessment of mobility of multiple sclerosis: An item response theory based evaluation of the MSWS-12 |
| Derek Sears Dr. Elliot M. Frohman |
Ocular Motor Pathophysiologic Signatures of Cognitive Dysfunction in Multiple Sclerosis |
| Yue (Carrie) Zhao Dr. Robert Bermel |
Optical coherence tomography measurement of progressive retinal nerve fiber layer degeneration in optic neuritis |
| Genzyme Corporation Research Scholars | |
| Benjamin Laitman Dr. Gareth John |
The Functional Role of Kruppel-like factor 6 Targets in Oligodendrocyte Differentiation |
| Mihaela Dan Privoaica Dr. Helen Tremlett |
Temporal Changes in Demographics of Multiple Sclerosis |
| Inserra Family Research Scholar | |
| Richard Dewey Dr. Elliot M. Frohman |
Investigatin of the Architecture of the Retinal-Hypothalamic Nervous System |
| Foundation of the CMSC Research Scholars | |
| Vaishak Amblee Dr. Robert Naismith |
Longitudinal analyses of Ambulatory Impairment and of Cognitive Decline by Thalamic Atrophy |
| Laura Anzaldi Dr. Adam Kaplin |
Tracking Purpose in Life of Patients with Multiple Sclerosis Who Are Members of an Online Support Network |
| Lukmon Babajide Dr. Fatma Gul |
Effectiveness of Medtronic Intrathecal Manager in spasticity management (myPTM) |
| Kayleigh Mei Lin Da Dr. Galina Vorobeychik |
Evaluation of Education in MS patients based on Learning Preferences and Expectations |
| Azmin Kahriman Dr. Carolina Ionete |
Study of Prevalence and Risk Factors by JCV Antibody Seroconversion of Multiple Sclerosis Patients |
| Adam M. Kruszewski Dr. Horea Rus |
RG-32 as a potential marker of relapses and response to treatment with Glatiramer Acetate in Multiple Sclerosis |